FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...
The Food and Drug Administration announced on Friday an approval of a new self- and caregiver-administered nose spray against ...
The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult ...
The US Food and Drug Administration (FDA) has approved AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...
The U.S. Food and Drug Administration (FDA) has approved FluMist for self-administration. On Friday, the FDA announced that ...
The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be ...
The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...
FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making ...
· FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider. · FluMist ...
AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on ...
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the ...